Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Dianemycin | C47H78O14 | 35865-33-9 | Details |
| Norvancomycin hydrochloride；Desmethyl-vancomycin hydrochloride | C65H74Cl3N9O24 | 213997-73-0 | Details |
| Norverapamil；(±)-Norverapamil;D591 | C26H36N2O4 | 67018-85-3 | Details |
| Natalizumab | C40H55N7O11S | 189261-10-7 | Details |
| Nrf2-IN-1 | C21H22ClN3O2 | 1610022-76-8 | Details |
| NHE3-IN-1 | C12H10ClN3S | 632355-68-1 | Details |
| Neurotoxin Inhibitor | C19H14N4OS | 951571-70-3 | Details |
| Nec-4 | C15H13ClFN3O | 1041644-43-2 | Details |
| NCGC00249987 | C16H11FN4O2S | 1384864-80-5 | Details |
| Nitazoxanide-d4；NSC-697855 D4;Nitazoxanide D4;NTZ D4 | C12H9N3O5S | 1246819-17-9 | Details |
| NCGC00229600 | C30H29N3O3 | 1338824-20-6 | Details |
| Netupitant metabolite Monohydroxy Netupitant；Monohydroxy Netupitant | C30H32F6N4O2 | 910808-12-7 | Details |
| Trifluoperazine dihydrochloride | C21H26Cl2F3N3S | 440-17-5 | Details |
| Nav1.7-IN-2 | C22H22FN5O2 | 1332295-35-8 | Details |
| Naveglitazar racemate | C25H26O6 | 916085-47-7 | Details |
| Nitroxazepine | C18H19N3O4 | 47439-36-1 | Details |
| Cefuroxime sodium | C16H15N4O8S.Na | 56238-63-2 | Details |
| NFAT Transcription Factor Regulator-1 | C17H10F6N4O2 | 245747-71-1 | Details |
| Netupitant metabolite Netupitant N-oxide；Netupitant N-oxide | C30H32F6N4O2 | 910808-11-6 | Details |
| Netropsin dihydrochloride | C18H27ClN10O3 | 18133-22-7 | Details |
| NaV1.7 inhibitor-1 | C23H30FNO4S | 1494585-79-3 | Details |
| Nevanimibe；ATR-101;PD-132301 | C27H39N3O | 133825-80-6 | Details |
| NF546 | C47H44N6Na4O17P4 | 1006028-37-0 | Details |
| Nav1.7 inhibitor | C15H11Cl3FNO4S | 1355631-24-1 | Details |
| NMDA-IN-1 | C20H23ClFN3O | 700878-19-9 | Details |
| Nav1.7-IN-6 | C25H25ClF6N2O4S | 1788066-71-6 | Details |
| NITD-349 | C17H20F2N2O | 1473450-62-2 | Details |
| Ceftriaxone sodium hydrate | C18H21N8NaO8S3 | 104376-79-6 | Details |
| Norbinaltorphimine dihydrochloride | C40H44ClN3O6 | 113158-34-2 | Details |
| NR1H4 activator 1 | C34H53NO7S | 2242855-68-9 | Details |
| Nifursemizone | C8H10N4O4 | 5579-89-5 | Details |
| Trans (2,3)-Dihydrotetrabenazine；(2R,3R,11bR)-rel-Dihydrotetrabenazine;(2R,3R,11bR)-rel-DHTBZ | C19H29NO3 | 171598-74-6 | Details |
| NB-598 Maleate | C31H35NO5S2 | 155294-62-5 | Details |
| Nilotinib-d6；AMN107 D6;Nilotinib D6 | C28H16D6F3N7O | 1268356-17-7 | Details |
| NSC232003 | C6H7N3O3 | 1905453-18-0 | Details |
| NCGC00247743 | C24H29N3O2 | 1435192-04-3 | Details |
| NF-56-EJ40 | C27H29N3O3 | 2380230-73-7 | Details |
| Nav1.1 activator 1 | C24H23F3N4O | 2332897-85-3 | Details |
| Necrostatin 2 | C13H12ClN3O2 | 852391-19-6 | Details |
| NMS-P715 | C35H39F3N8O3 | 1202055-32-0 | Details |
| NMS-859 | C15H12ClN3O3S | 1449236-96-7 | Details |
| NEO 376 | C20H24ClN3O | 496921-73-4 | Details |
| NK-1 Antagonist 1；Rolapitant intermediate | C25H23F6N5O2 | 873947-10-5 | Details |
| Sisomicin Sulfate | C19H39N5O11S | 53179-09-2 | Details |
| Cefoperazone sodium salt | C25H28N9NaO8S2 | 62893-20-3 | Details |
| Nebracetam hydrochloride | C12H17ClN2O | 1177279-49-0 | Details |
| NS-3-008 hydrochloride | C14H24ClN3 | 1172854-54-4 | Details |
| NCI172112；NSC268497;NSC172112 | C14H23Cl2N3O2 | 56605-16-4 | Details |
| NPS ALX Compound 4a | C25H25N3O2S | 299433-10-6 | Details |
| Netupitant metabolite N-desmethyl Netupitant；N-desmethyl Netupitant | C29H30F6N4O | 290296-72-9 | Details |
| Naquotinib mesylate；ASP8273 (mesylate) | C31H46N8O6S | 1448237-05-5 | Details |
| NPB | C29H31Cl2N3O2 | 2247491-97-8 | Details |
| NED-3238 | C17H28BN3O4 | 2389062-09-1 | Details |
| NPS ALX Compound 4a dihydrochloride | C25H26ClN3O2S | 1781934-44-8 | Details |
| NNC 55-0396 | C30H39ClFN3O2 | 357400-13-6 | Details |
| Ned 19 | C30H31FN4O3 | 874374-25-1 | Details |
| Nepafenac-d5；AHR-9434 D5;Nepafenac D5;AL-6515 D5 | C15H14N2O2 | 1246814-53-8 | Details |
| Necrostatin 2 S enantiomer | C13H12ClN3O2 | 852391-20-9 | Details |
| NSC 601980 (analog) | C15H14N4 | 91757-46-9 | Details |
| NCX899 | C23H33N3O8 | 690655-41-5 | Details |
| NRA-0160 | C24H23F2N3OS | 204718-47-8 | Details |
| Nifedipine-d6；Nifedipine D6;BAY-a-1040 D6 | C17H12D6N2O6 | 1188266-14-9 | Details |
| Nimesulide D5 | C13H7D5N2O5S | 1330180-22-7 | Details |
| Ethidium bromide；EtBr;Homidium bromide;EB | C21H20BrN3 | 1239-45-8 | Details |
| NCT-506 | C25H23FN4O3S | 2231098-99-8 | Details |
| NSC117079 | C20H15N3O7S2 | 500363-63-3 | Details |
| Nav1.7-IN-3 | C17H20ClFN4O2S2 | 1788872-06-9 | Details |
| Naspm trihydrochloride | C22H35ClN4O | 1049731-36-3 | Details |
| Navitoclax-piperazine | C47H56ClF3N6O5S3 | 2143096-93-7 | Details |
| Niperotidine | C20H26N4O5S | 84845-75-0 | Details |
| Nicardipine-d3 hydrochloride；Nicardipine D3 hydrochloride;YC-93 D3 | C26H26D3N3O6 | 1432061-50-1 | Details |
| NBTGR | C17H18N6O6S | 13153-27-0 | Details |
| CB-103 | C15H18N2O | 218457-67-1 | Details |
| NB-598 hydrochloride | C27H32ClNOS2 | 136719-25-0 | Details |
| Nexopamil racemate | C24H40N2O3 | 116759-35-4 | Details |
| Nourseothricin sulfate | C44H82N18O21S | 96736-11-7 | Details |
| NS8593 hydrochloride | C17H17N3.ClH | 875755-24-1 | Details |
| NIM811；SDZ NIM811;(Melle-4)cyclosporin | C62H111N11O12 | 143205-42-9 | Details |
| Bacitracin | C66H102N17O16S | 1405-87-4 | Details |
| Acetylcholine chloride | C7H16ClNO2 | 60-31-1 | Details |
| NecroX-5 | C26H35N3O6S2 | 1383718-29-3 | Details |
| Niraparib metabolite M1；Niraparib carboxylic acid metabolite M1;M1 metabolite of niraparib | C19H19N3O2 | 1476777-06-6 | Details |
| NNC45-0781 | C27H29NO3 | 207277-66-5 | Details |
| NSC 146109 hydrochloride | C17H17ClN2S | 59474-01-0 | Details |
| nor-NOHA acetate；Nω-Hydroxy-nor-L-arginine acetate | C5H12N4O3 ? 2C2H4O2 | 1140844-63-8 | Details |
| NB-360 | C21H19F4N5O2 | 1262857-73-7 | Details |
| Nevanimibe hydrochloride | C27H40ClN3O | 133825-81-7 | Details |
| NCT-505 | C27H28FN5O3S | 2231079-74-4 | Details |
| NAN-190 hydrobromide | C23H28BrN3O3 | 115338-32-4 | Details |
| Nosantine racemate；NPT-15392 racemate | C14H22N4O2 | 75166-67-5 | Details |
| NIC3 | C26H36N2O4 | 494830-67-0 | Details |
| Naspm；1-Naphthylacetyl spermine | C22H34N4O | 122306-11-0 | Details |
| Naphthoquine phosphate | C24H31ClN3O5P | 173531-58-3 | Details |
| NS19504 | C10H9BrN2S | 327062-46-4 | Details |
| Nateglinide D5；Senaglinide D5;A4166 D5 | C19H22D5NO3 | 1227666-13-8 | Details |
| Norverapamil-d7；D591 D7;(±)-Norverapamil D7;Norverapamil D7 | C26H29D7N2O4 | 263175-44-6 | Details |
| NOT Receptor Modulator 1；2-(3-(2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl)phenyl)propan-2-ol | C22H19ClN2O | 1015231-98-7 | Details |
| NMDI14 | C21H25N3O4S | 307519-88-6 | Details |
| Naratriptan D3 Hydrochloride；GR-85548A D3 | C17H25ClN3O2S | 1190021-64-7 | Details |
| NBDHEX | C12H15N3O4S | 787634-60-0 | Details |
| Product Total： Product Page： | ||||
| 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 | ||||